Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000229747 | SCV000285005 | benign | Cystic fibrosis | 2024-04-22 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000593269 | SCV000703051 | benign | not specified | 2016-10-26 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002257534 | SCV002529717 | benign | Hereditary pancreatitis | 2020-11-05 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV000229747 | SCV002621388 | benign | Cystic fibrosis | 2014-12-16 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV003736654 | SCV004563953 | benign | not provided | 2023-11-06 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001833243 | SCV002075872 | likely benign | CFTR-related disorder | 2018-04-09 | no assertion criteria provided | clinical testing |